MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary

Metastasis is responsible for the majority of cancer‐related deaths. Particularly, challenging is the management of metastatic cancer of unknown primary site (CUP), whose tissue of origin (TOO) remains undetermined even after extensive investigations and whose therapy is rather unspecific and poorly...

Descripción completa

Detalles Bibliográficos
Autores principales: Laprovitera, Noemi, Riefolo, Mattia, Porcellini, Elisa, Durante, Giorgio, Garajova, Ingrid, Vasuri, Francesco, Aigelsreiter, Ariane, Dandachi, Nadia, Benvenuto, Giuseppe, Agostinis, Federico, Sabbioni, Silvia, Berindan Neagoe, Ioana, Romualdi, Chiara, Ardizzoni, Andrea, Trerè, Davide, Pichler, Martin, D'Errico, Antonietta, Ferracin, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486570/
https://www.ncbi.nlm.nih.gov/pubmed/34075699
http://dx.doi.org/10.1002/1878-0261.13026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486570/
https://www.ncbi.nlm.nih.gov/pubmed/34075699
http://dx.doi.org/10.1002/1878-0261.13026

Ejemplares similares